France· FR:67140625
EYLEA 114,3 mg/mL, solution injectable en seringue préremplie
A medicinal product containing aflibercept, registered in France by BAYER AG (ALLEMAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- AFLIBERCEPT
- Manufacturer
- BAYER AG (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009303031221 seringue(s) préremplie(s) en verre de 0,184 mlEUR 392.56
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aflibercept in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenEylea 114,3 mg/ml Injektionsvätska, lösningBayer AG
- CzechiaEYLEABayer AG, Leverkusen
- SpainEYLEA 114,3 MG/ML SOLUCION INYECTABLEBayer Ag
- IrelandEylea 114.3 mg/ml solution for injectionBayer AG
- IcelandEyleaBayer AG*
- BelgiumEylea 114.3 mg/mlBayer
- NetherlandsEylea 114,3 mg/ml oplossing voor injectieBayer AG
- NorwayEyleaBayer AG
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Vgenfli
- Iceland · Afiveg, Afqlir
- Liechtenstein · Afiveg, Afqlir
- Norway · Afiveg, Afqlir
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/de6da14d-2996-4dcd-b471-4fc6dcf113af GET /v1/drugs/de6da14d-2996-4dcd-b471-4fc6dcf113af?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67140625",
"date_amm": "2024-08-31",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/12/797",
"substance": "AFLIBERCEPT",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intravitréenne",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about aflibercept.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.